$INO Becoming more and more evident that Inovio may have to go at this alone without funding. Could be a scary ride. How do multiple companies getting 2 rounds of major funding before inovio does? How come the belief is that inovio needs data to receive funding when every other company has gotten their funding before data. I hate to “cry wolf with PR” but my god now more than ever we need a bomb this week.
@Timmus $INO PR volcano will erupt soon. 1) Results from animal challenge trials on ferrets 2) Results from NHP trials 3) Per-reviewed results from human trials in USA 4) Start of P 2/3 trials on INO-4800 in USA 5) Results from P1 human trials in South Korea 6) Results from P1 human trials in China 7) INO being listed in South Korean Stock Market 8) South Korean institutions investing $50M in INO 9) Start of P2 human trials on INO 3107 against RRP 10) Start of Human primate trials under OWS These ones been programmed long ago and been scheduled for next few weeks already. Then some of the following should take a place in following weeks as well: 11) Upgrages from analysts 12) More instititutions buying big chunks of shares. (Ark bought above 1M shares on 26.06.2020) 13) CEPI funding ($8B budget) 14) GAVI funding ($8.8B budget) 15) Warp Speed funding ($#B budget) 16) Gates foundation funding ($#B budget) 17) IVI funding ($#B budget) 18) DOD contract (7,5M doses at $19 each)